Research map: Should serotonin-noradrenaline reuptake inhibitors be considered the most effective neuromodulators for irritable bowel syndrome?

Back to the article

Papers in this map

  1. Effects of venlafaxine on gastrointestinal symptoms, depression, anxiety, stress, and quality of life in patients with the moderate-to-severe irritable bowel syndrome · Pardis Adhamian · 2020 · 21 citations · Cited by this paper
  2. Letter in reply: should SNRIs be considered the most effective neuromodulators for IBS? · Mais Khasawneh · 2026 · Cites this paper
  3. A patient-driven agenda for liver cirrhosis research · 2026 · Related
  4. Investigation the Effectiveness of Duloxetine in Quality of Life and Symptoms of Patients with Irritable Bowel Syndrome · Razieh Salehian · 2021 · 18 citations · Cited by this paper
  5. International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials · 2026 · Related
  6. Effects of Duloxetine on Gastrointestinal Symptoms, Depression, Anxiety, Stress, and Quality of Life in Patients with the Moderate-to-Severe Irritable Bowel Syndrome · Mohammad Reza Sharbafchi · 2023 · 7 citations · Cited by this paper
  7. Toward a CKLM framework for integrated clinical trial design · 2026 · Related
  8. Comparison of the Effect of Duloxetine and Imipramine in the Treatment of Patients with Diarrhea Dominant Irritable Bowel Syndrome · Sattar Jafari · 2024 · 5 citations · Cited by this paper
  9. Large language models for detecting colorectal polyps in endoscopic images—further research is required · 2026 · Related
  10. Efficacy of gut-brain neuromodulators and brain-gut behaviour therapies for irritable bowel syndrome: systematic review and network meta-analysis · Mais Khasawneh · 2026 · 3 citations · Cited by this paper
  11. USP20 promotes CD8 + T cell exhaustion and impairs KRAS G12D inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer · 2026 · Related
  12. Galectin-14, a primate-specific oncofetal protein, impairs anti-tumour immunity in hepatocellular carcinoma by driving elevated heparan sulphate modification · 2026 · Related
  13. Cancer neuroscience in cholangiocarcinoma: from perineural invasion to neuroimmune control · 2026 · Related
  14. Cryptogenic steatotic liver disease: a lean phenotype associated with increased liver-related mortality · 2026 · Related
  15. Safety and efficacy of extended surveillance intervals following colorectal endoscopic submucosal dissection: an international multicentre study · 2026 · Related

Source: OpenAlex (CC0)